Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Shapiro

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Asia-Pacific Journal of Clinical Oncology|April 19, 2021
Patient demographics and management landscape of metastatic colorectal cancer in the third-line setting: Real-world data in an australian populationSandy Tun Min, Aflah Roohullah, Annette Tognela, et al.
JCO Clinical Cancer Informatics|April 11, 2025
Machine Learning Models of Early Longitudinal Toxicity Trajectories Predict Cetuximab Concentration and Metastatic Colorectal Cancer Survival in the Canadian Cancer Trials Group/AGITG CO.17/20 TrialsDanielle Lilly Nicholls, Maria C Xu, Luna Zhan, et al.
Annals of Medicine and Surgery (2012)|June 8, 2026
Predicting recurrence patterns and outcomes following resection of pancreatic ductal adenocarcinoma: a contemporary real-world data cohort studyEden Mane, Mark Tacey, Ben Loveday, et al.
Internal Medicine Journal|September 20, 2018
Chemotherapy and biologic use in the routine management of metastatic colorectal cancer in Australia: is clinical practice following the evidence?Christine Semira, Hui-Li Wong, Kathryn Field, et al.
Clinical Colorectal Cancer|September 13, 2020
Real-World Treatment and Outcomes of Metastatic Colorectal Cancer Patients With a Poor or Very Poor Performance StatusAvraham Travers, Azim Jalali, Stephen Begbie, et al.
Clinical Genitourinary Cancer|May 4, 2025
Treatment patterns and outcomes for younger patients with metastatic castration-resistant prostate cancer (mCRPC); An Australian prospective registry studyColin Williams, Andrisha-Jade Inderjeeth, Wei Hong, et al.
Clinical Colorectal Cancer|March 13, 2016
Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal CancerHui-Li Wong, Belinda Lee, Kathryn Field, et al.
Cancer Medicine|October 16, 2018
Fc-gamma receptor polymorphisms, cetuximab therapy, and overall survival in the CCTG CO.20 trial of metastatic colorectal cancerDaniel Shepshelovich, Amanda R Townsend, Osvaldo Espin-Garcia, et al.
Asia-Pacific Journal of Clinical Oncology|November 26, 2016
The impact of bevacizumab in metastatic colorectal cancer with an intact primary tumor: Results from a large prospective cohort studyBelinda Lee, Hui-Li Wong, Mark Tacey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2024
Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical TrialsJoao Paulo Solar Vasconcelos, Nan Chen, Emma Titmuss, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Asia-Pacific Journal of Clinical Oncology|April 19, 2021
Patient demographics and management landscape of metastatic colorectal cancer in the third-line setting: Real-world data in an australian populationSandy Tun Min, Aflah Roohullah, Annette Tognela, et al.
JCO Clinical Cancer Informatics|April 11, 2025
Machine Learning Models of Early Longitudinal Toxicity Trajectories Predict Cetuximab Concentration and Metastatic Colorectal Cancer Survival in the Canadian Cancer Trials Group/AGITG CO.17/20 TrialsDanielle Lilly Nicholls, Maria C Xu, Luna Zhan, et al.
Annals of Medicine and Surgery (2012)|June 8, 2026
Predicting recurrence patterns and outcomes following resection of pancreatic ductal adenocarcinoma: a contemporary real-world data cohort studyEden Mane, Mark Tacey, Ben Loveday, et al.
Internal Medicine Journal|September 20, 2018
Chemotherapy and biologic use in the routine management of metastatic colorectal cancer in Australia: is clinical practice following the evidence?Christine Semira, Hui-Li Wong, Kathryn Field, et al.
Clinical Colorectal Cancer|September 13, 2020
Real-World Treatment and Outcomes of Metastatic Colorectal Cancer Patients With a Poor or Very Poor Performance StatusAvraham Travers, Azim Jalali, Stephen Begbie, et al.
Clinical Genitourinary Cancer|May 4, 2025
Treatment patterns and outcomes for younger patients with metastatic castration-resistant prostate cancer (mCRPC); An Australian prospective registry studyColin Williams, Andrisha-Jade Inderjeeth, Wei Hong, et al.
Clinical Colorectal Cancer|March 13, 2016
Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal CancerHui-Li Wong, Belinda Lee, Kathryn Field, et al.
Cancer Medicine|October 16, 2018
Fc-gamma receptor polymorphisms, cetuximab therapy, and overall survival in the CCTG CO.20 trial of metastatic colorectal cancerDaniel Shepshelovich, Amanda R Townsend, Osvaldo Espin-Garcia, et al.
Asia-Pacific Journal of Clinical Oncology|November 26, 2016
The impact of bevacizumab in metastatic colorectal cancer with an intact primary tumor: Results from a large prospective cohort studyBelinda Lee, Hui-Li Wong, Mark Tacey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2024
Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical TrialsJoao Paulo Solar Vasconcelos, Nan Chen, Emma Titmuss, et al.
Pageof 8